The global OTC artificial tears market size reached US$ 5.2 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 7.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2023-2032.
Over the Counter (OTC) artificial tears are eye drops that are used for lubricating eyes and providing relief from pain, discomfort, burning, redness, photophobia and irritation in the eyes. They are manufactured using dextran, glycerin, propylene glycol, hydroxypropyl methylcellulose (HPMC) and carboxymethylcellulose. Artificial tears are widely used for the treatment of dry eyes, which is a medical condition when sufficient moisture or lubrication is not generated on the conjunctiva, cornea or entire surface of the eye. OTC artificial tears are biocompatible and aid in stabilizing the tear film, promoting healing and minimizing tear evaporation. In addition to this, OTC artificial tears are also available in ointment, spray, emulsion, solution and gel forms that are highly convenient use.
2. What is the expected growth rate of the global OTC artificial tears market during 2024-2032?
3. What are the key factors driving the global OTC artificial tears market?
4. What has been the impact of COVID-19 on the global OTC artificial tears market?
5. What is the breakup of the global OTC artificial tears market based on the product?
6. What is the breakup of the global OTC artificial tears market based on the container type?
7. What is the breakup of the global OTC artificial tears market based on formulation?
8. What is the breakup of the global OTC artificial tears market based on the application?
9. What is the breakup of the global OTC artificial tears market based on the distribution channel?
10. What are the key regions in the global OTC artificial tears market?
11. Who are the key players/companies in the global OTC artificial tears market?
Over the Counter (OTC) artificial tears are eye drops that are used for lubricating eyes and providing relief from pain, discomfort, burning, redness, photophobia and irritation in the eyes. They are manufactured using dextran, glycerin, propylene glycol, hydroxypropyl methylcellulose (HPMC) and carboxymethylcellulose. Artificial tears are widely used for the treatment of dry eyes, which is a medical condition when sufficient moisture or lubrication is not generated on the conjunctiva, cornea or entire surface of the eye. OTC artificial tears are biocompatible and aid in stabilizing the tear film, promoting healing and minimizing tear evaporation. In addition to this, OTC artificial tears are also available in ointment, spray, emulsion, solution and gel forms that are highly convenient use.
OTC Artificial Tears Market Trends:
The rising geriatric population that is prone to chronic eye-related disorders is one of the key factors driving the growth of the market. Due to the increasing prevalence of dry eye syndrome (DES), diabetes and nutritional deficiencies, there is a rising demand for OTC artificial tears to provide immediate relief from discomfort in the eyes. Additionally, the increasing utilization of electronics, such as smartphones, televisions (TVs) and laptops, leading to excessive screen time and eye fatigue, is positively impacting the adoption of OTC artificial tears. Various product innovations, such as the development of variants fortified with blink-activated coatings, are providing a thrust to the market growth. These coatings provide ocular hydration to patients suffering from evaporative dry eye syndrome. In line with this, the widespread product adoption with contact lenses to facilitate the flow of oxygen to the cornea and prevent dryness on the surface of the eyes is favoring the market growth. Other factors, including rising levels of pollution, especially in the urban regions, along with the increasing health consciousness among the masses, are anticipated to drive the market toward growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global OTC artificial tears market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on product, container type, formulation, application and distribution channel.Breakup by Product:
- Solution
- Ointment
- Emulsion
- Gel
- Spray Solution
- Suspensions
Breakup by Container Type:
- Plastic Single Dose Container
- Plastic Multi-Dose Container
- Others
Breakup by Formulation:
- Preservative Based
- Non-Preservative Based
Breakup by Application:
- Dry Eye Syndrome
- Allergies
- Infections
- UV and Blue Light Protection
- Contact Lens Moisture Retention
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Drug Store and Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Johnson & Johnson, Nicox S.A., OASIS Medical, OCuSOFT Inc., Santen Pharmaceutical Co. Ltd., Similasan Corporation, Sun Pharmaceutical Industries Ltd. and URSAPHARM Arzneimittel GmbH
Key Questions Answered in This Report
1. What was the size of the global OTC artificial tears market in 2023?2. What is the expected growth rate of the global OTC artificial tears market during 2024-2032?
3. What are the key factors driving the global OTC artificial tears market?
4. What has been the impact of COVID-19 on the global OTC artificial tears market?
5. What is the breakup of the global OTC artificial tears market based on the product?
6. What is the breakup of the global OTC artificial tears market based on the container type?
7. What is the breakup of the global OTC artificial tears market based on formulation?
8. What is the breakup of the global OTC artificial tears market based on the application?
9. What is the breakup of the global OTC artificial tears market based on the distribution channel?
10. What are the key regions in the global OTC artificial tears market?
11. Who are the key players/companies in the global OTC artificial tears market?
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global OTC Artificial Tears Market
6 Market Breakup by Product
7 Market Breakup by Container Type
8 Market Breakup by Formulation
9 Market Breakup by Application
10 Market Breakup by Distribution Channel
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- AbbVie Inc.
- Akorn Inc.
- Alcon
- Bausch Health Companies Inc.
- Johnson & Johnson
- Nicox S.A.
- OASIS Medical
- OCuSOFT Inc.
- Santen Pharmaceutical Co. Ltd.
- Similasan Corporation
- Sun Pharmaceutical Industries Ltd
- URSAPHARM Arzneimittel GmbH.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 146 |
Published | March 2024 |
Forecast Period | 2023 - 2032 |
Estimated Market Value ( USD | $ 5.2 Billion |
Forecasted Market Value ( USD | $ 7.8 Billion |
Compound Annual Growth Rate | 4.6% |
Regions Covered | Global |
No. of Companies Mentioned | 12 |